Biotech: Biologics and cell therapy products

3P Biopharmaceuticals has the GMP (Good Manufacturing Practices) certification issued by the AEMPS for the manufacture and release of biological active substances, the release of biological drugs and the release of sterile products for both human and veterinary use and for the manufacture and release of cell therapy product: human allogeneic adult stem cells extracted from hearth tissue an "in vitro“ expanded.

3P Biopharmaceuticals receives funding agreement with ENISA, the National Innovation Company

3P Biopharmaceuticals receives funding agreement with ENISA, the National Innovation Company

The funding agreement with ENISA of 450,000 Euros was designed to complete the plant with more technical equipment, with the objective of enhancing 3P Biopharmaceuticals’ productivity and competitiveness.

3P Biopharmaceuticals, a biotechnology company dedicated to the development of biologicals and cell therapy products has obtained the funding for 450,000 Euros with ENISA, the National Company of Innovation.